Crohn-betegség: vizsgálatok itt: Egyesült Királyság

In Egyesült Királyság 38 Also abroad 424

38 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.

3. fázisTaking people
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Where
Bristol, Cambridge, Doncaster, Exeter, Huddersfield, London, Oxford, Southampton, West Midlands
Életkor
16 év to 80 év
People
1200 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06430801 · EU 2023-508636-61-00
3. fázisTaking people
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Where
London, Prescot
Életkor
18 év and over
People
1380 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06651281 · EU 2024-513533-20-00
3. fázisTaking people
A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
Where
Birmingham, London, Sheffield
Életkor
2 év to 17 év
People
100 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07298421 · EU 2025-523318-96-00
3. fázisTaking people
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Where
Glasgow, London, Manchester, Oxford, Sheffield
Életkor
2 év to 17 év
People
120 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT05923073 · EU 2023-504735-41-00
3. fázisTaking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Sheffield, Stoke-on-Trent
Életkor
3 év to 64 év
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
2/3. fázisTaking people
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Where
Birmingham, Cambridge, Glasgow, Greater Manchester, London, Rainhill, Stockport
Életkor
18 év and over
People
1092 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07196722 · EU 2025-521382-27-00
No phaseTaking people
A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)
Where
Harrow
Életkor
18 év and over
People
220
Run by
Janssen-Cilag Ltd.
See details and how to joinNCT07242248
No phaseTaking people
A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease
Where
Bury, Cambridge, Cottingham, Dudley, Llandough, London, Oxford, Southampton, Winchester
Életkor
18 év and over
People
378 worldwide
Run by
Alimentiv Inc.
See details and how to joinNCT07363044
3. fázisTaking people
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Where
Greater London, Iselworth, London, Norwich, Wolverhampton
Életkor
18 év and over
People
530 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07499232
3. fázisTaking people
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Where
Birmingham, Bury, Cardiff, Dundee, Dundonald, Exeter, Glasgow, London, Newcastle upon Tyne, Oxford
Életkor
18 év and over
People
460 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07577843 · EU 2026-525922-39-00
2. fázisTaking people
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Where
Belfast, Cambridge, London
Életkor
18 év to 75 év
People
268 worldwide
Run by
Takeda
See details and how to joinNCT06233461 · EU 2023-506704-14-00
2. fázisTaking people
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Where
Bury, Cambridge, Dagenham, London
Életkor
18 év to 75 év
People
99 worldwide
Run by
Sanofi
See details and how to joinNCT06958536 · EU 2024-517016-30-00
2. fázisTaking people
NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease
Where
London
Életkor
18 év and over
People
320 worldwide
Run by
Agomab Spain S.L.U.
See details and how to joinNCT07683325
No phaseTaking people
Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study
Where
Coventry, Harrow, London, Newcastle upon Tyne, Oxford
Életkor
18 év and over
People
100
Run by
University Hospitals Coventry and Warwickshire NHS Trust
See details and how to joinNCT06579443
3. fázisTaking people
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Where
Bristol, Bury, Llanrhystud, London, Newcastle upon Tyne, Stockport
Életkor
16 év to 80 év
People
425 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06819891 · EU 2024-513054-30-00
3. fázisTaking people
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Where
Cambridge, Cottingham, London, Norwich, Rochdale
Életkor
16 év to 80 év
People
980 worldwide
Run by
Sanofi
See details and how to joinNCT07184931
3. fázisTaking people
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Where
Birmingham, London, Sheffield
Életkor
2 év to 17 év
People
110 worldwide
Run by
AbbVie
See details and how to joinNCT05995353 · EU 2022-502050-14-00
3. fázisTaking people
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Where
Cambridge, Harrow, Liverpool, London, Newcastle upon Tyne, North Shields, Nottingham
Életkor
16 év to 80 év
People
600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06819878 · EU 2024-513053-69-00
3. fázisTaking people
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Where
London, Oxford, Sheffield
Életkor
2 év to 19 év
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT04844606
3. fázisTaking people
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Where
Edinburgh, Headington, London, Manchester, Sheffield, Whitechapel
Életkor
2 év to 17 év
People
90 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05509777 · EU 2024-511472-32-00
2. fázisTaking people
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Where
Bristol, Cardiff, Coventry, Edinburgh, Glasgow, London, Newcastle upon Tyne, Oxford, Wolverhampton
Életkor
18 év to 75 év
People
590 worldwide
Run by
AbbVie
See details and how to joinNCT06548542 · EU 2024-513009-30-00
No phaseTaking people
Fibrosis Associated Protein Inhibitor (FAPI) Radiotracer-based Imaging to Identify Fibrotic Intestinal Crohn's Disease
Where
Edinburgh
Életkor
18 év to 90 év
People
30
Run by
University of Edinburgh
See details and how to joinNCT07152431
2. fázisTaking people
A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease
Where
Oxford
Életkor
18 év to 75 év
People
20
Run by
Takeda
See details and how to joinNCT07403968
No phaseTaking people
PIBD-SETQuality: the Inception Cohort and Safety Registry
Where
London
Életkor
0 év to 19 év
People
1500 worldwide
Run by
Erasmus Medical Center
See details and how to joinNCT03571373
No phaseTaking people
NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study
Where
Nottingham
Életkor
16 év and over
People
240
Run by
University of Nottingham
See details and how to joinNCT06956703